Performance in Delivering Clinical Research Lancashire Care NHS Foundation Trust Q3 2016-17 – – Target Number Number Target Number Date Research Integrated Of Of Date To Of Date That Agreed to Ethics Research Of Patients Patients Recruit Patients The Trial Number Of Reason For recruit Id Committee Name of Trial Agreed Closed To Study Closure Of Comments target Reference System (Enter (Enter At The Trial number of Number Number Agreed Same In Same In Agreed Recruited patients Both If Both If Target Only One Only One Date Number) Number) A Randomized, Double-blind, controlled, Parallel Group, Comparative, Sponsor Multicentre, closed Phase 2 early due Clinical Study Date Withdrawn to 167986 1 3 3 05/05/2016 3 to Evaluate Agreed 6 By Sponsor Agreed Efficacy and Safety of Two Doses of LND101001 in Patients with Mild to Moderate Alzheimer’s Disease STARBEAM: Randomised, double blind, parallel group, placebo Sponsor closed fixed dose early due study of Lu Date Withdrawn to 14/SS/1018 149117 6 6 25/05/2016 6 AE58054 in Agreed By Sponsor Agreed patients with Alzheimer’s disease treated with donepezil; Study 2
Performance in Delivering Clinical Research – Lancashire Care NHS Foundation Trust – Q3 2016-17 Id Research Ethics Committee Reference Number Integrated Research System Number Name of Trial Target Of Number Of Patients Agreed (Enter Same In Both If Only One Number) Number Of Patients Agreed (Enter Same In Both If Only One Number) Target Date To Recruit Date Agreed to recruit target number of patients Number Of Patients At The Agreed Target Date Date That The Trial Closed To Number Of Study Recruited Reason For Closure Of Trial Comments 167986 A Randomized, Double-blind, Parallel Group, Comparative, Multicentre, Phase 2 Clinical Study to Evaluate Efficacy and Safety of Two Doses of LND101001 in Patients with Mild to Moderate Alzheimer’s Disease Agreed 1 3 Date Agreed 3 05/05/2016 3 Withdrawn By Sponsor Sponsor closed early due to 14/SS/1018 149117 STARBEAM: Randomised, double blind, parallel group, placebo controlled, fixed dose study of Lu AE58054 in patients with Alzheimer’s disease treated with donepezil; Study 2 Agreed 6 6 Date Agreed 6 25/05/2016 6 Withdrawn By Sponsor Sponsor closed early due to
Performance%20in%20Delivering%20Clinical%20Research%20-%20Q3%202016-17.docx